Testing guide
Biomarker testing Australia
How biomarker testing works in Australia: Medicare vs private panels, common marker categories, pathology networks, and membership options with retesting.
Read guide →Educational only; not medical advice
Start here if you want the model, not a single marker. These guides explain preventative and longevity testing, what a reference interval is versus a decision limit, what Medicare actually funds, how often to test, how tracking works, and how Australian pathology access is organised.
Part of the Hemexa guides. Educational only; not medical advice.
Testing guide
How biomarker testing works in Australia: Medicare vs private panels, common marker categories, pathology networks, and membership options with retesting.
Read guide →Tracking guide
How Australians track pathology PDFs over time: upload apps, spreadsheets, and membership platforms that include coordinated testing and retesting.
Read guide →Testing guide
How preventative blood testing works in Australia: Medicare vs private panels, what markers to include, costs, GP-reviewed requests, and retest cadence.
Read guide →Longevity guide
What longevity blood tests measure, which biomarkers to include, how Australian options compare to Function Health, and how to choose a panel or membership.
Read guide →Testing guide
What a blood test reference range means in Australia, how it differs from a clinical decision limit, why in-range is not a clean bill of health, and why optimal range is not an RCPA term.
Read guide →Testing guide
What blood tests Medicare covers in Australia: the MBS screening rule, the check-up direction, episode coning, current item fees, and which markers stay private.
Read guide →Testing guide
How often Australians should get blood tests: what RACGP and college guidelines actually recommend, why some markers need a shorter gap, and how an annual baseline plus six-month retest differs from a check-up.
Read guide →Start your membership in the member app. Or browse all 76–80 markers before you decide.